We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
254 hedge funds and large institutions have $4.42B invested in Alnylam Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 113 increasing their positions, 63 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
79% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 63
29% more funds holding in top 10
Funds holding in top 10: 7 → 9 (+2)
11% more call options, than puts
Call options by funds: $56.3M | Put options by funds: $50.9M
8% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 36
2% less funds holding
Funds holding: 260 → 254 (-6)
29% less capital invested
Capital invested by funds: $6.22B → $4.42B (-$1.8B)
Holders
254
Holders Change
-6
Holders Change %
-2.31%
% of All Funds
6.77%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.24%
New
33
Increased
113
Reduced
63
Closed
36
Calls
$56.3M
Puts
$50.9M
Net Calls
+$5.36M
Net Calls Change
+$9.76M
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$85.6M |
| 2 |
Royal London Asset Management
United Kingdom
|
+$70.3M |
| 3 |
VAM
Visium Asset Management
New York
|
+$45.9M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$43.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$36.5M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$50.7M |
| 2 |
Jennison Associates
New York
|
-$34.5M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$17.9M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$17.8M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$14.2M |
